Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.89 | -$0.51 | -$0.70 |
| Q2 2026 | 1 | -$0.60 | -$0.34 | -$0.47 |
| Q3 2026 | 1 | -$0.75 | -$0.43 | -$0.59 |
| Q4 2026 | 1 | -$0.71 | -$0.41 | -$0.56 |
| Q1 2027 | 1 | -$0.64 | -$0.36 | -$0.50 |
| Q2 2027 | 1 | -$0.64 | -$0.36 | -$0.50 |
| Q3 2027 | 1 | -$0.64 | -$0.36 | -$0.50 |
| Q4 2027 | 1 | -$0.63 | -$0.35 | -$0.49 |
PAVmed Inc last posted its earnings results on Friday, August 14th, 2026. The company reported $-0.87 earnings per share for the quarter, missing analysts' consensus estimates of $-0.47 by $0.4. The company had revenue of 33.00 K for the quarter and had revenue of 71.00 K for the year. PAVmed Inc has generated $-6 earnings per share over the last year ($-5.63 diluted earnings per share) and currently has a price-to-earnings ratio of -0.24. PAVmed Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2026 | Q2 2026 | N/A | -$0.87 | N/A | $48.00 K | $33.00 K |
| 05/14/2026 | Q1 2026 | N/A | -$4.42 | N/A | $74.00 K | $22.00 K |
| 03/27/2026 | Q4 2025 | N/A | -$2.37 | N/A | $25.00 K | $52.00 K |
| 11/12/2025 | Q3 2025 | N/A | -$8.70 | N/A | $12.50 K | $5.00 K |
| 08/13/2025 | Q2 2025 | -$3.90 | -$22.20 | -18.3 | $10.00 K | $6.00 K |
| 05/14/2025 | Q1 2025 | N/A | $38.26 | N/A | $10.00 K | $8.00 K |
| 03/24/2025 | Q4 2024 | -$3.30 | $3.61 | 6.91 | $20.00 K | $10.00 K |
| 11/13/2024 | Q3 2024 | N/A | $192.84 | N/A | $1.09 M | $996.00 K |
| 08/12/2024 | Q2 2024 | N/A | -$35.75 | N/A | $1.20 M | $979.00 K |
| 05/13/2024 | Q1 2024 | N/A | -$78.62 | N/A | $1.05 M | $1.01 M |
| 03/25/2024 | Q4 2023 | N/A | -$58.07 | N/A | $1.05 M | $1.05 M |
| 11/13/2023 | Q3 2023 | N/A | -$71.35 | N/A | $658.00 K | $791.00 K |
| 08/14/2023 | Q2 2023 | N/A | -$63.01 | N/A | $525.00 K | $166.00 K |
| 05/15/2023 | Q1 2023 | N/A | -$83.45 | N/A | $225.00 K | $446.00 K |
| 03/13/2023 | Q4 2022 | N/A | -$97.76 | N/A | $275.00 K | $112.00 K |
| 11/14/2022 | Q3 2022 | N/A | -$131.34 | N/A | $233.33 K | $76.00 K |
| 08/15/2022 | Q2 2022 | N/A | -$132.45 | N/A | $262.50 K | $0 |
| 05/16/2022 | Q1 2022 | N/A | -$88.30 | N/A | $225.00 K | $189.00 K |
| 04/05/2022 | Q4 2021 | N/A | -$90.06 | N/A | $462.50 K | $300.00 K |
| 11/22/2021 | Q3 2021 | -$0.00 | -$66.41 | -66.41 | $275.00 K | $200.00 K |
The conference call for PAVmed Inc's latest earnings report can be listened to online.
The conference call transcript for PAVmed Inc's latest earnings report can be read online.
PAVmed Inc (:PAVM) has a recorded annual revenue of $71.00 K.
PAVmed Inc (:PAVM) has a recorded net income of $401.00 K.PAVmed Inc has generated $-5.63 earnings per share over the last four quarters.
PAVmed Inc (:PAVM) has a price-to-earnings ratio of -0.24 and price/earnings-to-growth ratio is 0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED